{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:37:21Z","timestamp":1775111841577,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":862,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CZ.2.16\/3.1.00\/22126"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/22126"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSMT-LK12052-KONTAKT II"],"award-info":[{"award-number":["MSMT-LK12052-KONTAKT II"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["15-14200S"],"award-info":[{"award-number":["15-14200S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["IKEM 00023001"],"award-info":[{"award-number":["IKEM 00023001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NT14050-3\/2013"],"award-info":[{"award-number":["NT14050-3\/2013"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NT14250-3\/2013"],"award-info":[{"award-number":["NT14250-3\/2013"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jchf.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T14:15:35Z","timestamp":1444054535000},"page":"829-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic\u00a0Heart\u00a0Failure"],"prefix":"10.1016","volume":"3","author":[{"given":"Peter","family":"Wohlfahrt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojtech","family":"Melenovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kotrc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Benes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonin","family":"Jabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janka","family":"Franekova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Jarolim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2015.05.012_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jchf.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/eci.12349","article-title":"FGF23 is associated with disease severity and prognosis in chronic heart failure","volume":"44","author":"Poelzl","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2015.05.012_bib3","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jchf.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study","volume":"25","author":"Ix","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jchf.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","article-title":"Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease","volume":"63","author":"Udell","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2362.2011.02631.x","article-title":"Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure","volume":"42","author":"Plischke","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","article-title":"A\u00a0decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jchf.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jchf.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"de Borst","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jchf.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000353593","article-title":"The role of fibroblast growth factor-23 in cardiorenal syndrome","volume":"123","author":"Kovesdy","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jchf.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4","volume":"9","author":"Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jchf.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCULATIONAHA.105.592733","article-title":"Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2013.06.046","article-title":"Relationships between right ventricular function, body composition, and prognosis in advanced heart failure","volume":"62","author":"Melenovsky","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2015.05.012_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated\u00a0receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jchf.2015.05.012_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of\u00a0a\u00a0new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jchf.2015.05.012_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.peptides.2012.08.003","article-title":"C-terminal FGF23 is a strong predictor of survival in systolic heart failure","volume":"37","author":"Gruson","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.jchf.2015.05.012_bib27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ncomms2240","article-title":"Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart","volume":"3","author":"Xie","year":"2012","journal-title":"Nature Commun"},{"key":"10.1016\/j.jchf.2015.05.012_bib28","doi-asserted-by":"crossref","first-page":"e000584","DOI":"10.1161\/JAHA.113.000584","article-title":"Fibroblast growth factor-23 and cardiac structure and function","volume":"3","author":"Agarwal","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2015.05.012_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D\u2013markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"Schierbeck","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCHEARTFAILURE.109.907899","article-title":"The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial","volume":"3","author":"Witham","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib31","first-page":"84","article-title":"A\u00a0randomized controlled trial of high dose vitamin D3 in patients with heart failure","volume":"1","author":"Boxer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2015.05.012_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2215\/CJN.09570912","article-title":"Serum FGF23 and risk of cardiovascular events in\u00a0relation to mineral metabolism and cardiovascular pathology","volume":"8","author":"Arnlov","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2015.05.012_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurjhf\/hfs002","article-title":"Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance","volume":"14","author":"Terrovitis","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib34","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1210\/jc.2013-1152","article-title":"Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study","volume":"98","author":"Jovanovich","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jchf.2015.05.012_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","article-title":"Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients","volume":"73","author":"Urena Torres","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2015.05.012_bib36","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2015.05.012_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","article-title":"Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure","volume":"7","author":"van Deursen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2015.05.012_bib39","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2015.05.012_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2796.2011.02503.x","article-title":"The\u00a0association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*","volume":"271","author":"Nymo","year":"2012","journal-title":"J\u00a0Intern Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177915004254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177915004254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T14:51:26Z","timestamp":1658242286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177915004254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213177915004254"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2015.05.012","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725842516.793512187","asserted-by":"object"}]},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic\u00a0Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}